Form: S-1

General form of registration statement for all companies including face-amount certificate companies

November 14, 2023

Documents

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-1

(Form Type)

 

TELOMIR PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

    Security Type  

Security Class

Title

   Fee Calculation or Carry Forward Rule   Maximum Aggregate Offering Price (1)(2)    

 

 

Fee Rate

     Amount of Registration Fee  
Fees to be paid   Equity   Common stock, no par value (3)   457(o)   $ 13,800,000       0.00014760     $ 2,037  
    Equity   Underwriter Warrants (4)   457(g)     —       —       —  
    Equity   Common stock issuable upon exercise of Underwriter Warrants (5)   457(o)     600,000       0.00014760       89  
        Total Offering Amounts       $ 14,400,000             $ 2,126  
        Total Fees Previously Paid                       $ —  
        Total Fee Offsets                       $ —  
        Net Fee Due                       $ 2,126  

 

  (1) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended. Includes shares to be sold upon exercise of the underwriters’ option to purchase additional shares.
  (2) Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
  (3) Includes shares of common stock which may be issued on exercise of a 45-day option granted to the underwriters to cover over-allotments.
  (4) No fee pursuant to Rule 457(g) under the Securities Act of 1933, as amended.
  (5) As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o), the proposed maximum aggregate offering price of the Underwriter Warrants is $600,000, which is equal to 5.0% of the aggregate number of shares of common stock sold in this offering, excluding the overallotment option, at an exercise price equal to 100% of the public offering price per share.